These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21112155)

  • 41. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
    Mason BJ
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
    Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acamprosate: A Review of Its Use in Alcohol Dependence.
    Plosker GL
    Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study.
    Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A
    Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind evaluation of homeopathy on cocaine craving: a randomized controlled pilot study.
    Adler UC; Acorinte AC; Calzavara FO; da Silva AA; de Toledo Cesar A; Adler MS; Martinez EZ; Galduróz JCF
    J Integr Med; 2018 May; 16(3):178-184. PubMed ID: 29625852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo.
    Dahl H; Hammarberg A; Franck J; Helander A
    Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial.
    Hammarberg A; Jayaram-Lindström N; Beck O; Franck J; Reid MS
    Psychopharmacology (Berl); 2009 Jul; 205(1):53-62. PubMed ID: 19319508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
    Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
    J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
    Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
    J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tinnitus treatment with acamprosate: double-blind study.
    Azevedo AA; Figueiredo RR
    Braz J Otorhinolaryngol; 2005; 71(5):618-23. PubMed ID: 16612523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acamprosate in alcohol dependence: how does it work?
    Littleton J
    Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate.
    Umhau JC; Schwandt ML; Usala J; Geyer C; Singley E; George DT; Heilig M
    Neuropsychopharmacology; 2011 May; 36(6):1178-86. PubMed ID: 21289601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
    Colagiuri B; Morley K; Boakes R; Haber P
    Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.